Cutting edge issues in primary sclerosing cholangitis

Clinical Reviews in Allergy and Immunology

Volumn 41, Issue 2, 2011, Pages 139-150

  Bowlus, Christopher L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Genetics; Innate immunity; Lymphocyte trafficking; Primary sclerosing cholangitis

Indexed keywords

BACTERIAL PROTEIN; CD51 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; COLONY STIMULATING FACTOR 1; GLUTAMIC ACID; HLA ANTIGEN; HLA ANTIGEN CLASS 2; HLA B8 ANTIGEN; HLA C ANTIGEN; HLA DR ANTIGEN; IMMUNOGLOBULIN G; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2 RECEPTOR BETA; INTERLEUKIN 6; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; LYSINE; MITOGEN ACTIVATED PROTEIN KINASE; MULTIDRUG RESISTANCE PROTEIN; PEPTIDOGLYCAN; PROTEIN; TNFAIP6 PROTEIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AFRICAN AMERICAN; AMINO ACID SUBSTITUTION; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL INFECTION; CHROMOSOME 13; CHROMOSOME 13Q; CHROMOSOME 2Q; CHROMOSOME 3P; CHROMOSOME 6P; DISEASE ASSOCIATION; ENTERITIS; GENE EXPRESSION PROFILING; GENE LINKAGE DISEQUILIBRIUM; GENE MAPPING; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; IMMUNOMODULATION; INNATE IMMUNITY; LIVER TRANSPLANTATION; LYMPHOCYTE MIGRATION; MACROPHAGE; NATURAL KILLER CELL; PARENT; PRIMARY SCLEROSING CHOLANGITIS; PROGENY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIBLING; SIGNAL TRANSDUCTION; SMOKING; SOCIAL STATUS; SWEDEN; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ADAPTIVE IMMUNITY; BACTERIAL INFECTIONS; BILE DUCTS; CHOLANGIOCARCINOMA; CHOLANGITIS, SCLEROSING; COMORBIDITY; FIBROSIS; HUMANS; IMMUNITY, INNATE; INFLAMMATORY BOWEL DISEASES; MALE; SEX FACTORS;

EID: 80054897554     PISSN: 10800549     EISSN: 15590267     Source Type: Journal    
DOI: 10.1007/s12016-010-8221-3     Document Type: Article

References (102)

1. R Chapman S Cullen 2008 Etiopathogenesis of primary sclerosing cholangitis World J Gastroenterol 14 3350 3359 18528932 1:CAS:528: DC%2BD1cXhtFylt7zP
2. CA Aoki CL Bowlus ME Gershwin 2005 The immunobiology of primary sclerosing cholangitis Autoimmun Rev 4 137 143 15823499 1:CAS:528: DC%2BD2MXkvFOquro%3D (Pubitemid 40488742)
3. R Saich R Chapman 2008 Primary sclerosing cholangitis, autoimmune hepatitis and overlap syndromes in inflammatory bowel disease World J Gastroenterol 14 331 337 18200656 (Pubitemid 351320842)
4. JH Aron CL Bowlus 2009 The immunobiology of primary sclerosing cholangitis Semin Immunopathol 31 383 397 19468733 1:CAS:528:DC%2BD1MXhtFOrsLnE
5. EV Loftus Jr GC Harewood CG Loftus, et al. 2005 PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis Gut 54 91 96 15591511 (Pubitemid 40007225)
6. JR Cangemi RH Wiesner SJ Beaver, et al. 1989 Effect of proctocolectomy for chronic ulcerative colitis on the natural history of primary sclerosing cholangitis Gastroenterology 96 790 794 2914641 1:STN:280:DyaL1M7itFeqtA%3D%3D (Pubitemid 19057601)
7. TH Florin N Pandeya GL Radford-Smith 2004 Epidemiology of appendicectomy in primary sclerosing cholangitis and ulcerative colitis: its influence on the clinical behaviour of these diseases Gut 53 973 979 15194646 1:STN:280:DC%2BD2czitVCkuw%3D%3D (Pubitemid 38824155)
8. SA Mitchell M Thyssen TR Orchard DP Jewell KA Fleming RW Chapman 2002 Cigarette smoking, appendectomy, and tonsillectomy as risk factors for the development of primary sclerosing cholangitis: a case control study Gut 51 567 573 12235082 1:STN:280:DC%2BD38vntlSntA%3D%3D
9. KJ van Erpecum SJ Smits PC van de Meeberg, et al. 1996 Risk of primary sclerosing cholangitis is associated with nonsmoking behavior Gastroenterology 110 1503 1506 8613056 (Pubitemid 26134083)
10. EV Loftus Jr WJ Sandborn WJ Tremaine, et al. 1996 Primary sclerosing cholangitis is associated with nonsmoking: a case-control study Gastroenterology 110 1496 1502 8613055 (Pubitemid 26134082)
11. RD Cohen SB Hanauer 1996 Protection from primary sclerosing cholangitis: smoke trails of just coattails? Gastroenterology 110 1658 1662 8613079 1:STN:280:DyaK283gtVGmuw%3D%3D (Pubitemid 26134106)
12. CL Bowlus CS Li TH Karlsen BA Lie C Selmi 2010 Primary sclerosing cholangitis in genetically diverse populations listed for liver transplantation: unique clinical and human leukocyte antigen associations Liver Transpl 16 1324 1330 21031548
13. A Bergquist G Lindberg S Saarinen U Broome 2005 Increased prevalence of primary sclerosing cholangitis among first-degree relatives J Hepatol 42 252 256 15664252 (Pubitemid 40143473)
14. A Bergquist SM Montgomery S Bahmanyar, et al. 2008 Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis Clin Gastroenterol Hepatol 6 939 943 18674735
15. X Yang SN Cullen JH Li RW Chapman DP Jewell 2004 Susceptibility to primary sclerosing cholangitis is associated with polymorphisms of intercellular adhesion molecule-1 J Hepatol 40 375 379 15123348 1:CAS:528: DC%2BD2cXhsFWju74%3D (Pubitemid 38230835)
16. CL Bowlus TH Karlsen U Broome, et al. 2006 Analysis of MAdCAM-1 and ICAM-1 polymorphisms in 365 Scandinavian patients with primary sclerosing cholangitis J Hepatol 45 704 710 16750586 1:CAS:528:DC%2BD28XhtVWqtrzO (Pubitemid 44466659)
17. TH Karlsen A Franke E Melum, et al. 2010 Genome-wide association analysis in primary sclerosing cholangitis Gastroenterology 138 1102 1111 19944697
18. E Schrumpf O Fausa O Forre JH Dobloug S Ritland E Thorsby 1982 HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepatobiliary disease Scand J Gastroenterol 17 187 191 6982501 1:STN:280:DyaL3s%2FktV2itA%3D%3D (Pubitemid 12185520)
19. RW Chapman Z Varghese R Gaul G Patel N Kokinon S Sherlock 1983 Association of primary sclerosing cholangitis with HLA-B8 Gut 24 38 41 6600227 1:STN:280:DyaL3s%2FotVOitg%3D%3D (Pubitemid 13170184)
20. JM Farrant DG Doherty PT Donaldson, et al. 1992 Amino acid substitutions at position 38 of the DR beta polypeptide confer susceptibility to and protection from primary sclerosing cholangitis Hepatology 16 390 395 1639348 1:CAS:528:DyaK38XlvV2qtLs%3D
21. A Spurkland S Saarinen KM Boberg, et al. 1999 HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations Tissue Antigens 53 459 469 10372541 1:STN:280:DyaK1M3pvFOmtA%3D%3D (Pubitemid 29224484)
22. TH Karlsen KM Boberg M Vatn, et al. 2007 Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis Genes Immun 8 275 278 17301827 1:CAS:528:DC%2BD2sXksFeltr4%3D (Pubitemid 46672059)
23. A Franke T Balschun TH Karlsen, et al. 2008 Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility Nat Genet 40 1319 1323 18836448 1:CAS:528:DC%2BD1cXhtlSkurjI
24. JR Oksenberg LF Barcellos BA Cree, et al. 2004 Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans Am J Hum Genet 74 160 167 14669136 1:CAS:528:DC%2BD2cXlvVOrtQ%3D%3D (Pubitemid 38085247)
25. K Wiencke A Spurkland E Schrumpf KM Boberg 2001 Primary sclerosing cholangitis is associated to an extended B8-DR3 haplotype including particular MICA and MICB alleles Hepatology 34 625 630 11584356 1:CAS:528: DC%2BD3MXns1Kju7s%3D (Pubitemid 32927984)
26. S Norris E Kondeatis R Collins, et al. 2001 Mapping MHC-encoded susceptibility and resistance in primary sclerosing cholangitis: the role of MICA polymorphism Gastroenterology 120 1475 1482 11313318 1:CAS:528: DC%2BD3MXjs1SrtL8%3D (Pubitemid 32322322)
27. W Bernal M Moloney J Underhill PT Donaldson 1999 Association of tumor necrosis factor polymorphism with primary sclerosing cholangitis J Hepatol 30 237 241 10068102 1:STN:280:DyaK1M7msFCksw%3D%3D (Pubitemid 29071186)
28. SA Mitchell J Grove A Spurkland, et al. 2001 Association of the tumour necrosis factor alpha -308 but not the interleukin 10-627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis Gut 49 288 294 11454808 1:STN:280:DC%2BD3Mvgtlehug%3D%3D (Pubitemid 32675125)
29. TH Karlsen KM Boberg M Olsson, et al. 2007 Particular genetic variants of ligands for natural killer cell receptors may contribute to the HLA associated risk of primary sclerosing cholangitis J Hepatol 46 899 906 17383044 1:CAS:528:DC%2BD2sXjvFamtbc%3D (Pubitemid 46529047)
30. SI Khakoo M Carrington 2006 KIR and disease: a model system or system of models? Immunol Rev 214 186 201 17100885 1:CAS:528:DC%2BD28XhtlClsrzM (Pubitemid 44707911)
31. JR Hov A Lleo C Selmi, et al. 2010 Genetic associations in Italian primary sclerosing cholangitis: heterogeneity across Europe defines a critical role for HLA-C J Hepatol 52 712 717 20347497 1:CAS:528:DC%2BC3cXlsFKksrg%3D
32. P Gaj A Habior M Mikula J Ostrowski 2008 Lack of evidence for association of primary sclerosing cholangitis and primary biliary cirrhosis with risk alleles for Crohn's disease in Polish patients BMC Med Genet 9 81 18715515
33. TH Karlsen J Hampe K Wiencke, et al. 2007 Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis Am J Gastroenterol 102 115 121 17100974 1:CAS:528:DC%2BD2sXhvVOmsL4%3D (Pubitemid 46072051)
34. MC Eike GB Nordang TH Karlsen, et al. 2008 The FCRL3-169T > C polymorphism is associated with rheumatoid arthritis and shows suggestive evidence of involvement with juvenile idiopathic arthritis in a Scandinavian panel of autoimmune diseases Ann Rheum Dis 67 1287 1291 18065500 1:STN:280:DC%2BD1crhtlWgtA%3D%3D
35. A Franke T Balschun TH Karlsen, et al. 2008 Replication of signals from recent studies of Crohn's disease identifies previously unknown disease loci for ulcerative colitis Nat Genet 40 713 715 18438405 1:CAS:528:DC%2BD1cXmsVejsbg%3D (Pubitemid 351748866)
36. SA Fisher M Tremelling CA Anderson, et al. 2008 Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease Nat Genet 40 710 712 18438406 1:CAS:528:DC%2BD1cXmsVejsb8%3D (Pubitemid 351748865)
37. RK Weersma PC Stokkers I Cleynen, et al. 2009 Confirmation of multiple Crohn's disease susceptibility loci in a large Dutch-Belgian cohort Am J Gastroenterol 104 630 638 19174780 1:CAS:528:DC%2BD1MXis1arur8%3D
38. V Keitel M Donner S Winandy R Kubitz D Haussinger 2008 Expression and function of the bile acid receptor TGR5 in Kupffer cells Biochem Biophys Res Commun 372 78 84 18468513 1:CAS:528:DC%2BD1cXmvFeku7Y%3D (Pubitemid 351778164)
39. Y Kawamata R Fujii M Hosoya, et al. 2003 A G protein-coupled receptor responsive to bile acids J Biol Chem 278 9435 9440 12524422 1:CAS:528: DC%2BD3sXhvV2isrY%3D (Pubitemid 36800434)
40. V Keitel K Cupisti C Ullmer WT Knoefel R Kubitz D Haussinger 2009 The membrane-bound bile acid receptor TGR5 is localized in the epithelium of human gallbladders Hepatology 50 861 870 19582812 1:CAS:528:DC%2BD1MXhtFKntLzN
41. L Henckaerts M Jaspers W Van Steenbergen, et al. 2009 Cystic fibrosis transmembrane conductance regulator gene polymorphisms in patients with primary sclerosing cholangitis J Hepatol 50 150 157 18992954 1:CAS:528: DC%2BD1cXhsVCkt77L
42. PG Blanco MM Zaman O Junaidi, et al. 2004 Induction of colitis in cftr-/- mice results in bile duct injury Am J Physiol Gastrointest Liver Physiol 287 G491 G496 15064232 1:CAS:528:DC%2BD2cXmvVKnu7s%3D
43. S Sheth JC Shea MD Bishop, et al. 2003 Increased prevalence of CFTR mutations and variants and decreased chloride secretion in primary sclerosing cholangitis Hum Genet 113 286 292 12783301 (Pubitemid 36992289)
44. E Girodon D Sternberg O Chazouilleres, et al. 2002 Cystic fibrosis transmembrane conductance regulator (CFTR) gene defects in patients with primary sclerosing cholangitis J Hepatol 37 192 197 12127423 1:CAS:528: DC%2BD38XlsVGqu7c%3D (Pubitemid 34833080)
45. JR Hov V Keitel JK Laerdahl, et al. 2010 Mutational characterization of the bile acid receptor TGR5 in primary sclerosing cholangitis PLoS ONE 5 e12403 20811628
46. Chan SW, Lim CJ, Chen L et al (2010) The hippo pathway in biological control and cancer development. J Cell Physiol. doi: 10.1002/jcp.22435
47. YQ Zhou YQ Chen JH Fisher MH Wang 2002 Activation of the RON receptor tyrosine kinase by macrophage-stimulating protein inhibits inducible cyclooxygenase-2 expression in murine macrophages J Biol Chem 277 38104 38110 12177064 1:CAS:528:DC%2BD38Xns1Cgurc%3D (Pubitemid 35154662)
48. M Raab H Wang Y Lu, et al. 2010 T cell receptor "inside-out" pathway via signaling module SKAP1-RapL regulates T cell motility and interactions in lymph nodes Immunity 32 541 556 20346707 1:CAS:528: DC%2BC3cXlslSisr4%3D
49. K Katagiri T Katakai Y Ebisuno Y Ueda T Okada T Kinashi 2009 Mst1 controls lymphocyte trafficking and interstitial motility within lymph nodes EMBO J 28 1319 1331 19339990 1:CAS:528:DC%2BD1MXjvV2ltbo%3D
50. P Goyette C Lefebvre A Ng, et al. 2008 Gene-centric association mapping of chromosome 3p implicates MST1 in IBD pathogenesis Mucosal Immunol 1 131 138 19079170 1:CAS:528:DC%2BD1cXhvFCnt74%3D
51. ME Himmel G Hardenberg CA Piccirillo TS Steiner MK Levings 2008 The role of T-regulatory cells and Toll-like receptors in the pathogenesis of human inflammatory bowel disease Immunology 125 145 153 18798918 1:CAS:528: DC%2BD1cXht1ansr3J
52. J Hampe A Franke P Rosenstiel, et al. 2007 A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1 Nat Genet 39 207 211 17200669 1:CAS:528:DC%2BD2sXpvFerug%3D%3D (Pubitemid 46184351)
53. Y Ogura DK Bonen N Inohara, et al. 2001 A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease Nature 411 603 606 11385577 1:CAS:528:DC%2BD3MXksVShur8%3D (Pubitemid 32531409)
54. JP Hugot M Chamaillard H Zouali, et al. 2001 Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease Nature 411 599 603 11385576 1:CAS:528:DC%2BD3MXksVShtLY%3D (Pubitemid 32531408)
55. CA O'Mahony JM Vierling 2006 Etiopathogenesis of primary sclerosing cholangitis Semin Liver Dis 26 3 21 16496229 (Pubitemid 43320723)
56. E Seki DA Brenner 2008 Toll-like receptors and adaptor molecules in liver disease: update Hepatology 48 322 335 18506843 1:CAS:528:DC%2BD1cXptFemu7o%3D (Pubitemid 351975556)
57. A Karrar U Broome T Sodergren, et al. 2007 Biliary epithelial cell antibodies link adaptive and innate immune responses in primary sclerosing cholangitis Gastroenterology 132 1504 1514 17408653 1:CAS:528: DC%2BD2sXlslKru7Y%3D (Pubitemid 46627575)
58. RG Cameron LM Blendis MG Neuman 2001 Accumulation of macrophages in primary sclerosing cholangitis Clin Biochem 34 195 201 11408017 1:CAS:528:DC%2BD3MXltl2hurY%3D (Pubitemid 32537671)
59. CT Wu JP Eiserich AA Ansari, et al. 2003 Myeloperoxidase-positive inflammatory cells participate in bile duct damage in primary biliary cirrhosis through nitric oxide-mediated reactions Hepatology 38 1018 1025 14512889 1:CAS:528:DC%2BD3sXovFGhu74%3D (Pubitemid 37221685)
60. K Tsuneyama K Harada N Kono, et al. 2001 Scavenger cells with gram-positive bacterial lipoteichoic acid infiltrate around the damaged interlobular bile ducts of primary biliary cirrhosis J Hepatol 35 156 163 11580136 1:CAS:528:DC%2BD3MXntFKhtrc%3D (Pubitemid 32803469)
61. CH Hobson TJ Butt DM Ferry J Hunter VS Chadwick MF Broom 1988 Enterohepatic circulation of bacterial chemotactic peptide in rats with experimental colitis Gastroenterology 94 1006 1013 3345870 1:CAS:528: DyaL1cXhvVCmt7o%3D
62. RP Anderson TJ Butt VS Chadwick 1992 Hepatobiliary excretion of bacterial formyl-methionyl peptides in rat. Structure activity studies Dig Dis Sci 37 248 256 1735343 1:CAS:528:DyaK38Xks1Okurc%3D
63. CH Hobson EC Roberts MF Broom DM Mellor RM Sherriff VS Chadwick 1990 Radio-immunoassay for formyl methionyl leucyl phenylalanine. I. Development and application to assessment of chemotactic peptide production by enteric bacteria J Gastroenterol Hepatol 5 32 37 2129421 1:STN:280:DyaK3MzlsFOmtQ%3D%3D (Pubitemid 20133724)
64. S Yamada M Ishii N Kisara R Nagatomi T Toyota 1999 Macrophages are essential for lymphocyte infiltration in formyl peptide-induced cholangitis in rat liver Liver 19 253 258 10395046 1:STN:280:DyaK1MzitV2luw%3D%3D (Pubitemid 29261593)
65. S Yamada M Ishii LS Liang T Yamamoto T Toyota 1994 Small duct cholangitis induced by N-formyl l-methionine l-leucine l-tyrosine in rats J Gastroenterol 29 631 636 8000512 1:CAS:528:DyaK2cXmslCjt7w%3D (Pubitemid 24308414)
66. SN Lichtman RB Sartor J Keku JH Schwab 1990 Hepatic inflammation in rats with experimental small intestinal bacterial overgrowth Gastroenterology 98 414 423 2295397 1:STN:280:DyaK3c7gvVGmtQ%3D%3D (Pubitemid 20037925)
67. SN Lichtman J Keku JH Schwab RB Sartor 1991 Hepatic injury associated with small bowel bacterial overgrowth in rats is prevented by metronidazole and tetracycline Gastroenterology 100 513 519 1985047 1:CAS:528:DyaK3MXktVSht7c%3D
68. SN Lichtman EE Okoruwa J Keku JH Schwab RB Sartor 1992 Degradation of endogenous bacterial cell wall polymers by the muralytic enzyme mutanolysin prevents hepatobiliary injury in genetically susceptible rats with experimental intestinal bacterial overgrowth J Clin Invest 90 1313 1322 1401067 1:CAS:528:DyaK38XmsV2nt74%3D
69. E Bjornsson A Cederborg A Akvist M Simren PO Stotzer I Bjarnason 2005 Intestinal permeability and bacterial growth of the small bowel in patients with primary sclerosing cholangitis Scand J Gastroenterol 40 1090 1094 16211716 (Pubitemid 41291359)
70. CY Ponsioen J Defoer FJ Ten Kate, et al. 2002 A survey of infectious agents as risk factors for primary sclerosing cholangitis: are Chlamydia species involved? Eur J Gastroenterol Hepatol 14 641 648 12072598 (Pubitemid 34666643)
71. AM Krasinskas Y Yao P Randhawa MP Dore AR Sepulveda 2007 Helicobacter pylori may play a contributory role in the pathogenesis of primary sclerosing cholangitis Dig Dis Sci 52 2265 2270 17393314 (Pubitemid 47246536)
72. SY Boomkens S de Rave RG Pot, et al. 2005 The role of Helicobacter spp. in the pathogenesis of primary biliary cirrhosis and primary sclerosing cholangitis FEMS Immunol Med Microbiol 44 221 225 15866219 1:CAS:528: DC%2BD2MXjslKgsb4%3D (Pubitemid 41373380)
73. RW Leong JJ Sung 2002 Review article: Helicobacter species and hepatobiliary diseases Aliment Pharmacol Ther 16 1037 1045 12030944 1:STN:280:DC%2BD383ptFSntA%3D%3D (Pubitemid 34680745)
74. J Pohl A Ring W Stremmel A Stiehl 2006 The role of dominant stenoses in bacterial infections of bile ducts in primary sclerosing cholangitis Eur J Gastroenterol Hepatol 18 69 74 16357622 (Pubitemid 43004884)
75. CA Aoki K Dawson TP Kenny ME Gershwin CL Bowlus 2006 Gene expression by PBMC in primary sclerosing cholangitis: evidence for dysregulation of immune mediated genes Clin Dev Immunol 13 265 271 17162367 1:CAS:528: DC%2BD2sXps1SitQ%3D%3D (Pubitemid 44950042)
76. CM Milner VA Higman AJ Day 2006 TSG-6: a pluripotent inflammatory mediator? Biochem Soc Trans 34 446 450 16709183 1:CAS:528:DC%2BD28XkvVGitb8%3D (Pubitemid 43954008)
77. AJ Grant PF Lalor M Salmi S Jalkanen DH Adams 2002 Homing of mucosal lymphocytes to the liver in the pathogenesis of hepatic complications of inflammatory bowel disease Lancet 359 150 157 11809275 (Pubitemid 34112549)
78. B Eksteen JR Mora EL Haughton, et al. 2009 Gut homing receptors on CD8 T-cells ARE retinoic acid dependent and not maintained by liver dendritic or stellate cells Gastroenterol 137 320 329 1:CAS:528:DC%2BD1MXovFOgtbw%3D
79. B Eksteen A Miles SM Curbishley, et al. 2006 Epithelial inflammation is associated with CCL28 production and the recruitment of regulatory T cells expressing CCR10 J Immunol 177 593 603 16785557 1:CAS:528:DC%2BD28XlvV2ntbc%3D (Pubitemid 43939173)
80. B Eksteen AJ Grant A Miles, et al. 2004 Hepatic endothelial CCL25 mediates the recruitment of CCR9+ gut-homing lymphocytes to the liver in primary sclerosing cholangitis J Exp Med 200 1511 1517 15557349 1:CAS:528: DC%2BD2cXhtVyiurvM (Pubitemid 39657298)
81. AJ Grant S Goddard J Ahmed-Choudhury, et al. 2002 Hepatic expression of secondary lymphoid chemokine (CCL21) promotes the development of portal-associated lymphoid tissue in chronic inflammatory liver disease Am J Pathol 160 1445 1455 11943728 1:CAS:528:DC%2BD38XjsFGjt7s%3D (Pubitemid 34411647)
82. AJ Grant PF Lalor SG Hubscher M Briskin DH Adams 2001 MAdCAM-1 expressed in chronic inflammatory liver disease supports mucosal lymphocyte adhesion to hepatic endothelium (MAdCAM-1 in chronic inflammatory liver disease) Hepatology 33 1065 1072 11343233 1:CAS:528:DC%2BD3MXjvVaiu7o%3D (Pubitemid 32378204)
83. R Kurkijarvi DH Adams R Leino T Mottonen S Jalkanen M Salmi 1998 Circulating form of human vascular adhesion protein-1 (VAP-1): increased serum levels in inflammatory liver diseases J Immunol 161 1549 1557 9686623 1:CAS:528:DyaK1cXltVehsrY%3D (Pubitemid 28380589)
84. YH Oo CJ Weston PF Lalor, et al. 2010 Distinct roles for CCR4 and CXCR3 in the recruitment and positioning of regulatory T cells in the inflamed human liver J Immunol 184 2886 2898 20164417 1:CAS:528:DC%2BC3cXis1yisLw%3D
85. YH Oo DH Adams 2010 The role of chemokines in the recruitment of lymphocytes to the liver J Autoimmun 34 45 54 19744827 1:CAS:528: DC%2BC3cXhtlGjsbs%3D
86. AT Borchers S Shimoda C Bowlus CL Keen ME Gershwin 2009 Lymphocyte recruitment and homing to the liver in primary biliary cirrhosis and primary sclerosing cholangitis Semin Immunopathol 31 309 322 19533132 1:CAS:528:DC%2BD1MXhtFOrsLbF
87. KJ Hillan KE Hagler RN MacSween, et al. 1999 Expression of the mucosal vascular addressin, MAdCAM-1, in inflammatory liver disease Liver 19 509 518 10661685 1:CAS:528:DC%2BD3cXkvVyltw%3D%3D (Pubitemid 30019065)
88. E Patsenker Y Popov F Stickel A Jonczyk SL Goodman D Schuppan 2008 Inhibition of integrin alphavbeta6 on cholangiocytes blocks transforming growth factor-beta activation and retards biliary fibrosis progression Gastroenterology 135 660 670 18538673 1:CAS:528:DC%2BD1cXhtVCqsL3O
89. M Trauner P Fickert E Halilbasic T Moustafa 2008 Lessons from the toxic bile concept for the pathogenesis and treatment of cholestatic liver diseases Wien Med Wochenschr 158 542 548 18998069
90. P Fickert G Zollner A Fuchsbichler, et al. 2002 Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles Gastroenterology 123 1238 1251 12360485 1:CAS:528:DC%2BD38Xotl2ns7Y%3D
91. Y Popov E Patsenker P Fickert M Trauner D Schuppan 2005 Mdr2 (Abcb4)-/- mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro- and antifibrogenic genes J Hepatol 43 1045 1054 16223543 1:CAS:528:DC%2BD2MXht1egsrjP (Pubitemid 41627991)
92. J Jahnel P Fickert C Langner, et al. 2009 Impact of experimental colitis on hepatobiliary transporter expression and bile duct injury in mice Liver Int 29 1316 1325 19558576 1:CAS:528:DC%2BD1MXht1GntL%2FL
93. P Fickert A Fuchsbichler M Wagner, et al. 2004 Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice Gastroenterology 127 261 274 15236191 1:CAS:528: DC%2BD2cXmsVShs7c%3D (Pubitemid 38962293)
94. P Fickert T Moustafa M Trauner 2007 Primary sclerosing cholangitis-the arteriosclerosis of the bile duct? Lipids Health Dis 6 3 17254334
95. JF Gallegos-Orozco E Yurk C N Wang, et al. 2005 Lack of association of common cystic fibrosis transmembrane conductance regulator gene mutations with primary sclerosing cholangitis Am J Gastroenterol 100 874 878 15784035 1:CAS:528:DC%2BD2MXktFart70%3D (Pubitemid 40592382)
96. JM McGill DM Williams CM Hunt 1996 Survey of cystic fibrosis transmembrane conductance regulator genotypes in primary sclerosing cholangitis Dig Dis Sci 41 540 542 8617131 1:STN:280:DyaK287pvF2lug%3D%3D (Pubitemid 26116410)
97. GU Denk H Bikker RH Lekanne Dit Deprez, et al. 2010 ABCB4 deficiency: a family saga of early onset cholelithiasis, sclerosing cholangitis and cirrhosis and a novel mutation in the ABCB4 gene Hepatol Res 40 937 941 20887599 1:CAS:528:DC%2BC3cXhtlSgt7nL
98. R Poupon L Arrive O Rosmorduc 2010 The cholangiographic features of severe forms of ABCB4/MDR3 deficiency-associated cholangiopathy in adults Gastroentérol Clin Biol 34 380 387 20537830 1:CAS:528: DC%2BC3cXpsVGhtrg%3D
99. C Pauli-Magnus R Kerb K Fattinger, et al. 2004 BSEP and MDR3 haplotype structure in healthy Caucasians, primary biliary cirrhosis and primary sclerosing cholangitis Hepatology 39 779 791 14999697 1:CAS:528: DC%2BD2cXjtlaiu7w%3D (Pubitemid 38337658)
100. O Rosmorduc B Hermelin PY Boelle RE Poupon R Poupon O Chazouilleres 2004 ABCB4 gene mutations and primary sclerosing cholangitis Gastroenterology 126 1220 1222 15057773 author reply 1222-3
101. A Stiehl G Rudolph P Sauer L Theilmann 1995 Biliary secretion of bile acids and lipids in primary sclerosing cholangitis. Influence of cholestasis and effect of ursodeoxycholic acid treatment J Hepatol 23 283 289 8550992 1:CAS:528:DyaK2MXoslSltL0%3D
102. TH Karlsen BA Lie K Frey Froslie, et al. 2006 Polymorphisms in the steroid and xenobiotic receptor gene influence survival in primary sclerosing cholangitis Gastroenterology 131 781 787 16952547 1:CAS:528:DC%2BD28XhtVKrurjF (Pubitemid 44307062)